trial

An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia

NCTId NCT00823199
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 10 (actual)
Sponsored by Bronx Psychiatric Center
Primary completion 2008-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
10 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2005-11
Primary completion
2008-08
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Allopurinal

Sponsors

Bronx Psychiatric CenterLead Sponsor

Investigators

1
Nigel Bark, MDPrincipal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
10
Phase
NA
Primary Completion Date
2008-08
Status
COMPLETED
relationships
The graph out of here
drug
Allopurinal
drug
lead_sponsor
Bronx Psychiatric Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Nigel Bark, MD
person